Knowledge Themes
Vaccine Technology: Conventional (Inactivated) vs Next-Gen (mRNA, Viral Vector, DNA)
Biosimilars: Cost-effectiveness, regulatory pathways, and difference from generics
Gene Therapy: Somatic vs Germline editing and the CRISPR-Cas9 revolution
India's Bio-economy: National Biopharma Mission and the 'Pharmacy of the World' status
Ethical and IPR challenges: Patent evergreening, bioethics, and data privacy in clinical trials
Structural Subtopics
- Recombinant DNA technology in medicine
- Mechanisms of mRNA and DNA vaccines
- CAR-T cell therapy applications and challenges
- CRISPR-Cas9 for treating genetic disorders
- Regulatory framework for biosimilars in India
- Principles of pharmacogenomics and personalized medicine
- Monoclonal antibodies in cancer immunotherapy
- Viral vectors and non-viral delivery systems in gene therapy
- Molecular diagnostics using PCR and ELISA
- Ethical concerns of germline gene editing
- Stem cell therapy and regenerative medicine
- Production of genetically engineered insulin and steroids
- Human Genome Project and its medical implications
- Biosafety and patenting issues in medical biotechnology
Study Material
Full AI-synthesized study material for Biotechnology in Medicine — Vaccines, Biosimilars & Gene Therapy is being calibrated.
View Legacy Notes →